CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
前收盤價
US$6.59
−US$0.03 · -0.45%
盤中時間採用ET。市場資料可能有所延遲。
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
日內區間
目前US$6.59
52週區間
目前US$6.59
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 |
|---|---|---|---|
| 營收 | 1355.4萬 USD | 1175.6萬 USD | 975.3萬 USD |
| 銷貨成本 | 638.1萬 USD | 537.9萬 USD | 426.2萬 USD |
| 毛利 | 717.3萬 USD | 637.7萬 USD | 549.1萬 USD |
| 研究與開發 | 1831萬 USD | 1512萬 USD | 933.3萬 USD |
| 銷售、一般及管理費用 | 1437.9萬 USD | 1117.4萬 USD | 750.5萬 USD |
| 營業費用 | 3268.9萬 USD | 2629.4萬 USD | 1683.8萬 USD |
| 利息收入 | 26.9萬 USD | 2.6萬 USD | 4.9萬 USD |
| 折舊和攤銷 | 56.7萬 USD | 52.1萬 USD | 38.8萬 USD |
| 營業利益 | −2551.6萬 USD | −1991.7萬 USD | −1134.7萬 USD |
| 淨利 | −2531.5萬 USD | −1989.8萬 USD | −1130.5萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。